Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (24092)	8/6/1998 3:49:00 PM
From: Machaon	Read Replies (1) \| Respond to of 32384

Good article Henry, thanks. Of course the "off label" law also applies to the big drugs companies also. At the current low biotech prices, I would expect some takeovers, but not in LGND's case. LGND has too many partnerships to be taken over. Nevertheless, there is going to be a lot of money to be made with drugs that have multiple applications. Even with the LGND stock doing so poorly, I still really like their future possibilities, especially in the "off label" market. Regards, Bob